Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

被引:23
|
作者
Inamori, Koji [1 ,2 ,3 ,4 ,5 ]
Togashi, Yosuke [1 ]
Fukuoka, Shota [1 ]
Akagi, Kiwamu [6 ]
Ogasawara, Kouetsu [7 ]
Irie, Takuma [1 ]
Motooka, Daisuke [8 ]
Kobayashi, Yoichi [9 ,10 ]
Sugiyama, Daisuke [9 ]
Kojima, Motohiro [11 ]
Shiiya, Norihiko [3 ,4 ,5 ]
Nakamura, Shota [8 ]
Maruyama, Shoichi [10 ]
Suzuki, Yutaka [12 ]
Ito, Masaaki [2 ]
Nishikawa, Hiroyoshi [1 ,9 ]
机构
[1] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunol, Res Inst, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp East NCCHE, Dept Colorectal Surg, Chiba, Japan
[3] Hamamatsu Univ, Div Cardiovasc, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ, Div Thorac, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[5] Hamamatsu Univ, Div Gen Endoscop & Breast Surg, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[6] Saitama Canc Ctr SCC, Div Mol Diag & Canc Prevent, Saitama, Japan
[7] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi, Japan
[8] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan
[10] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan
[11] NCCHE, Div Pathol, Chiba, Japan
[12] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan
关键词
REGULATORY T-CELLS; MICROSATELLITE INSTABILITY; PD-1; BLOCKADE; CLINICOPATHOLOGICAL FEATURES; EXPRESSION; TUMORS; COLON; INFILTRATION; MULTICENTER; IMMUNOLOGY;
D O I
10.1172/jci.insight.137365
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Patients with colorectal cancers (CRCs) generally exhibit improved survival through intensive lymph node (LN) dissection. However, recent progress in cancer immunotherapy revisits the potential importance of regional LNs, where T cells are primed to attack tumor cells. To elucidate the role of regional LN, we investigated the immunological status of nonmetastatic regional LN lymphocytes (LNLs) in comparison with those of the tumor microenvironment (tumor-infiltrating lymphocytes; TILs) using flow cytometry and next-generation sequencing. LNLs comprised an intermediate level of the effector T cell population between peripheral blood lymphocytes (PBLs) and TILs. Significant overlap of the T cell receptor (TCR) repertoire was observed in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) CRCs with high tumor mutation burden (TMB), although limited TCRs were shared between nonmetastatic LNs and primary tumors in microsatellite stable/MMR proficient (MSS/pMMR) CRC patients with low TMB. In line with the overlap of the TCR repertoire, an excessive LN dissection did not provide a positive impact on long-term prognosis in our MSI-H/dMMR CRC cohort (n = 130). We propose that regional LNs play an important role in antitumor immunity, particularly in MSI-H/dMMR CRCs with high TMB, requiring care to be taken regarding excessive nonmetastatic LN dissection in MSI-H/dMMR CRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Endometrial Tumors with MSI-H and dMMR Share a Similar Tumor Immune Microenvironment
    Song, Yunfeng
    Gu, Ye
    Hu, Xiang
    Wang, Mengfei
    He, Qizhi
    Li, Yiran
    ONCOTARGETS AND THERAPY, 2021, 14 : 4485 - 4497
  • [22] The clinical and genomic characteristics of MSI-h/dMMR lung cancer.
    Qin, Jianwen
    Shi, Dongsheng
    Yin, Yan
    Bin Liu
    Wang, Lei
    Sun, Tingting
    Zhang, Qin
    Qi, Chuang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] MSI-H/dMMR and cancer immunotherapy: current state and future implications
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (06): : 345 - 347
  • [24] Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
    Zhang, Xuan
    Wu, Tao
    Cai, Xinyi
    Dong, Jianhua
    Xia, Cuifeng
    Zhou, Yongchun
    Ding, Rong
    Yang, Renfang
    Tan, Jing
    Zhang, Lijuan
    Zhang, Ya
    Wang, Yuqin
    Dong, Chao
    Li, Yunfeng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Real-world experience of immune checkpoint inhibitors in MSI-H/dMMR metastatic colorectal cancer in a tertiary cancer center in Saudi Arabia
    Ajina, R.
    Alhareeri, A.
    Philip, W.
    Alsekait, N.
    Alarifi, N.
    Alismail, H.
    Alshieban, S.
    Almuzzaini, B.
    Alshammari, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S117 - S117
  • [26] MSI-H/dMMR mCRC: ICIs in the first line?
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (12) : 748 - 748
  • [27] MSI-H/dMMR mCRC: ICIs in the first line?
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2021, 18 : 748 - 748
  • [28] Immune checkpoint inhibitors for patients with isolated peritoneal carcinomatosis from dMMR/MSI-H colorectal cancer, a BIG-RENAPE collaboration
    Barraud, Solenn
    Tougeron, David
    Villeneuve, Laurent
    Eveno, Clarisse
    Bayle, Arnaud
    Parc, Yann
    Pocard, Marc
    Andre, Thierry
    Cohen, Romain
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (05) : 673 - 678
  • [29] Immunotherapy outcomes in dMMR/MSI-H and/or TMB-H metastatic colorectal cancer (CRC) with peritoneal metastases (PM).
    Mosalem, Osama M.
    Elhariri, Ahmed
    Wiest, Nathaniel Edward
    Kamatham, Saivaishnavi
    Abdel-Razeq, Nayef Hikmat
    Jones, Jeremy Clifton
    Sonbol, Mohamad B.
    Jin, Zhaohui
    Babiker, Hani M.
    Bekaii-Saab, Tanios S.
    Majeed, Umair
    Starr, Jason S.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 163 - 163
  • [30] Pathological response following neoadjuvant immunotherapy and imaging characteristics in dMMR/MSI-H locally advanced colorectal cancer
    Deng, Zijian
    Luo, Yajun
    Chen, Xiaoli
    Pan, Tao
    Rui, Yuanyi
    Hu, Hai
    Yan, Jin
    Zhang, Ke
    Luo, Cheng
    Song, Bo
    FRONTIERS IN IMMUNOLOGY, 2024, 15